Larvol Cliniclarvol.hashnode.devยทSep 27, 2024Outcomes of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma and Deteriorating Liver FunctionBackground The treatment landscape for patients with unresectable hepatocellular carcinoma (uHCC) has recently expanded. However, there is an unmet need for effective treatment options in patients with Child-Pugh (CP) B liver function. Lenvatinib is ...CancerAdd a thoughtful commentNo comments yetBe the first to start the conversation.
